| 1. |  ABB Ltd Zurich, Switzerland | | - | VIEW |
| 2. |  Adamed Pharma Pieńków, Poland | | Commercial | VIEW |
| 3. |  Ajanta Pharma Mumbai, India | | Commercial | VIEW |
| 4. |  Alexion Pharmaceuticals Boston, USA | | Commercial | VIEW |
| 5. |  Alkaloid AD Skopje Skopje, North Macedonia | | Commercial | VIEW |
| 6. |  Alkem Laboratories Mumbai, India | | Commercial | VIEW |
| 7. |  Almirall Barcelona, Spain (Ronda General Mitre, 151, Barcelona, 08022) | | Phase 1, Phase 2, Phase 3, Commercial | VIEW |
| 8. |  Amazon.com, Inc. Seattle, USA | | - | VIEW |
| 9. |  Amgen Thousand Oaks, California, United States | | Discovery through Commercial | VIEW |
| 10. |  Amneal Pharmaceuticals Bridgewater, New Jersey, USA | | Commercial | VIEW |
| 11. |  | | Commercial | VIEW |
| 12. |  Asian Institute of Technology Pathum Thani, Thailand | | Discovery | VIEW |
| 13. |  Aspen Pharmacare Holdings Limited uMhlanga, South Africa | | Commercial (Focus on post-patent branded generics rather than R&D pipeline) | VIEW |
| 14. |  Astellas Pharma Inc. Tokyo, Japan | | Discovery to Phase 3 | VIEW |
| 15. |  AstraZeneca Cambridge, United Kingdom | | Phase 1|Phase 2|Phase 3|Pre-registration|Commercial | VIEW |
| 16. |  Aurobindo Pharma Limited Hyderabad, India | | Commercial | VIEW |
| 17. |  BASF Ludwigshafen, Germany | | Commercial | VIEW |
| 18. |  Bangkok Dusit Medical Services (BDMS) Bangkok, Thailand | | Commercial | VIEW |
| 19. |  Bausch + Lomb Corporation Bridgewater, New Jersey, USA | | Commercial | VIEW |
| 20. |  Bausch Health Laval, Canada | | Commercial | VIEW |
| 21. |  | | Discovery through Commercial | VIEW |
| 22. |  BeOne Medicines Basel, Switzerland (redomiciled May 2025); originally Cambridge, Massachusetts | | Commercial and Clinical (Phase 1-3) | VIEW |
| 23. |  Berlin Pharmaceutical Industry Co., Ltd. Bangkok, Thailand | | Commercial | VIEW |
| 24. |  Berlin-Chemie AG Berlin, Germany | | Commercial | VIEW |
| 25. |  Bio Farma Bandung, Indonesia | | Commercial | VIEW |
| 26. |  Biocon Limited Bengaluru, India | | Commercial, Phase 3, Phase 2, Phase 1 | VIEW |
| 27. |  Biogen Cambridge, Massachusetts, USA | | Phase 1-Phase 3; Commercial | VIEW |
| 28. |  Bionorica SE Neumarkt in der Oberpfalz, Germany | | Commercial | VIEW |
| 29. |  Biotest AG Dreieich, Germany | | Phase 3 | VIEW |
| 30. |  Boehringer Ingelheim Ingelheim am Rhein, Germany (near Mainz and Frankfurt) | | Phase 1|Phase 2|Phase 3|Commercial | VIEW |
| 31. |  Boryung Seoul, South Korea | | Commercial | VIEW |
| 32. |  Bracco Imaging S.p.A. Milan, Italy | | Commercial | VIEW |
| 33. |  Bristol Myers Squibb Princeton, New Jersey, United States | | Phase 1-3 and Commercial | VIEW |
| 34. |  | | Commercial | VIEW |
| 35. |  CSC Financial Co., Ltd. Beijing, China | | - | VIEW |
| 36. |  CSL Limited Melbourne, Australia | | Commercial | VIEW |
| 37. |  CSL Limited (CSL Behring is the largest division) Melbourne, Australia (corporate); King of Prussia, USA (CSL Behring) | | Phase 1 through Commercial | VIEW |
| 38. |  CSL Seqirus Maidenhead, United Kingdom | | Commercial | VIEW |
| 39. |  Celltrion Incheon, South Korea | | Commercial | VIEW |
| 40. |  Cencora Conshohocken, Pennsylvania, United States | | Commercial (as distributor/logistics provider) | VIEW |
| 41. |  Cencora Conshohocken, Pennsylvania, USA | | Commercial | VIEW |
| 42. |  Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (CTTQ) Lianyungang/Nanjing, China | | Commercial | VIEW |
| 43. |  Chiesi Farmaceutici Parma, Italy | | Phase 1|Phase 2|Phase 3|Commercial | VIEW |
| 44. |  China Resources Double-Crane Pharmaceutical Co., Ltd. Beijing, China | | Commercial | VIEW |
| 45. |  China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. Shenzhen, China | | Commercial | VIEW |
| 46. |  Chong Kun Dang Pharmaceutical Corp. Seoul, South Korea | | Commercial | VIEW |
| 47. |  Chugai Pharma Taiwan Ltd. Taipei, Taiwan | | Commercial | VIEW |
| 48. |  Chugai Pharmaceutical Co., Ltd. Tokyo, Japan | | Commercial | VIEW |
| 49. |  | | Commercial | VIEW |
| 50. |  Citi Pharma Limited Lahore, Punjab, Pakistan | | Commercial | VIEW |
| 51. |  Coca-Cola Europacific Partners Uxbridge, United Kingdom | | - | VIEW |
| 52. |  | | Commercial | VIEW |
| 53. |  DLL (De Lage Landen Financial Services) Eindhoven, Netherlands (Global); Wayne, PA (US) | | Commercial | VIEW |
| 54. |  Daewon Pharmaceutical Co., Ltd. Seoul, South Korea | | Commercial | VIEW |
| 55. |  Daewoong Pharmaceutical Seoul, South Korea | | Commercial | VIEW |
| 56. |  Daiichi Sankyo Chuo, Tokyo, Japan | | Phase 1|Phase 2|Phase 3|Commercial | VIEW |
| 57. |  Daiichi Sankyo Co., Ltd. Tokyo, Japan | | Commercial | VIEW |
| 58. |  Daiichi Sankyo Co., Ltd. Tokyo, Japan | | Commercial | VIEW |
| 59. |  | | Commercial | VIEW |
| 60. |  Dawnrays Pharmaceutical Suzhou, China | | Commercial | VIEW |
| 61. |  Dechra Pharmaceuticals Northwich, United Kingdom | | Commercial | VIEW |
| 62. |  Dong-A Socio Holdings Co., Ltd. Seoul, South Korea | | Commercial | VIEW |
| 63. |  Dr. Reddy's Laboratories Ltd. Hyderabad, India | | Commercial | VIEW |
| 64. |  EMD Serono Boston Seaport District, MA, USA (200 Pier 4 Boulevard, Boston, MA) | | Phase 1, 2, 3, and Commercial | VIEW |
| 65. |  Ecolab Inc. Saint Paul, USA | | Commercial | VIEW |
| 66. |  Eczacıbaşı Group Istanbul, Turkey | | Commercial | VIEW |
| 67. |  Eczacıbaşı Pharmaceutical and Industrial Investment Co. Istanbul, Turkey | | Commercial | VIEW |
| 68. |  Eisai Co., Ltd. Tokyo, Japan | | Commercial | VIEW |
| 69. |  Eisai Co., Ltd. Tokyo, Japan | | Commercial | VIEW |
| 70. |  Eisai Co., Ltd. Tokyo, Japan | | Commercial | VIEW |
| 71. |  Eisai Pharmaceuticals India Mumbai, India | | Commercial | VIEW |
| 72. |  Elanco Animal Health Indianapolis, USA | | Commercial | VIEW |
| 73. |  Eli Lilly and Company Indianapolis, Indiana, USA | | Phase 1-Phase 3 and Commercial | VIEW |
| 74. |  | | Commercial | VIEW |
| 75. |  Esteve Healthcare Barcelona, Spain | | Commercial | VIEW |
| 76. |  Eurofarma Itapevi, São Paulo, Brazil | | Multiple stages (Discovery to Commercial) | VIEW |
| 77. |  Export-Import Bank of Korea Seoul, South Korea | | Commercial | VIEW |
| 78. |  | | Commercial | VIEW |
| 79. |  Ferozsons Laboratories Limited Lahore, Pakistan | | Commercial | VIEW |
| 80. |  | | Commercial | VIEW |
| 81. |  Ferring Pharmaceuticals Saint-Prex, Switzerland | | Commercial | VIEW |
| 82. |  Fidelity Investments Boston, USA | | Commercial | VIEW |
| 83. |  Fosun Pharma Shanghai, China | | Commercial | VIEW |
| 84. |  Fresenius Kabi Bad Homburg, Germany | | Commercial | VIEW |
| 85. |  GC Biopharma Corp. (formerly Green Cross Corporation) Yongin, Gyeonggi Province, South Korea | | Multiple stages (Discovery through Commercial) | VIEW |
| 86. |  GSK plc London, United Kingdom | | Phase 1|Phase 2|Phase 3|Commercial | VIEW |
| 87. |  Gedeon Richter Budapest, Hungary | | Commercial | VIEW |
| 88. |  Getz Pharma Karachi, Pakistan | | Commercial | VIEW |
| 89. |  Gilead Sciences Foster City, California, United States | | Commercial | VIEW |
| 90. |  Glenmark Pharmaceuticals Mumbai, India | | Commercial | VIEW |
| 91. |  Grand Pharmaceutical Group Wuhan, China | | Commercial | VIEW |
| 92. |  Grifols, S.A. Sant Cugat del Vallès (Barcelona), Spain | | Phase 3 | VIEW |
| 93. |  Grupo Farma Caracas, Venezuela | | Commercial | VIEW |
| 94. |  Grünenthal Aachen, Germany | | Commercial | VIEW |
| 95. |  H. Lundbeck A/S Valby, Copenhagen, Denmark | | Commercial | VIEW |
| 96. |  Haleon Weybridge, United Kingdom | | Commercial | VIEW |
| 97. |  | | Commercial | VIEW |
| 98. |  Heraeus Holding GmbH Hanau, Germany | | Commercial | VIEW |
| 99. |  | | Commercial | VIEW |
| 100. |  Hetero Healthcare Ltd Hyderabad, India | | Commercial | VIEW |
| 101. |  Hexal AG Holzkirchen, Germany | | Commercial | VIEW |
| 102. |  Hikma Pharmaceuticals London, United Kingdom | | Commercial | VIEW |
| 103. |  Hudson Insurance Group New York, USA | | Commercial | VIEW |
| 104. |  Humanwell Healthcare Wuhan, China | | Commercial | VIEW |
| 105. |  IBM (International Business Machines Corporation) Armonk, New York, USA | | - | VIEW |
| 106. |  Incepta Pharmaceuticals Ltd. Dhaka, Bangladesh | | Commercial | VIEW |
| 107. |  Indivior Richmond, Virginia, United States | | Phase 2-3 | VIEW |
| 108. |  Intas Pharmaceuticals Ltd. Ahmedabad, India | | Commercial | VIEW |
| 109. |  Ipca Laboratories Ltd Mumbai, India | | Commercial | VIEW |
| 110. |  Ipsen Boulogne-Billancourt, France | | Commercial | VIEW |
| 111. |  Italfarmaco Group Milan, Italy | | Commercial | VIEW |
| 112. |  JS Group Karachi, Pakistan | | N/A | VIEW |
| 113. |  JW Pharmaceutical Gwacheon, South Korea | | Commercial | VIEW |
| 114. |  Jaba Recordati Porto Salvo, Portugal | | Commercial | VIEW |
| 115. |  Jamp Pharma Group Boucherville, Canada | | Commercial | VIEW |
| 116. |  Jazz Pharmaceuticals Dublin, Ireland | | Phase 1 through Commercial | VIEW |
| 117. |  Johnson & Johnson New Brunswick, New Jersey, USA | | Discovery|Preclinical|Phase 1|Phase 2|Phase 3|Commercial | VIEW |
| 118. |  Johnson & Johnson New Brunswick, New Jersey, USA | | Commercial | VIEW |
| 119. |  Jubilant Pharmova Limited Noida, India | | Phase 2 | VIEW |
| 120. |  Kaneka Corporation Osaka, Japan | | Commercial | VIEW |
| 121. |  Keenova Therapeutics (formerly Endo Pharmaceuticals/Mallinckrodt Specialty Brands) Dublin, Ireland | | Commercial|Phase 1-3 | VIEW |
| 122. |  Kenvue Summit, New Jersey, USA | | Commercial | VIEW |
| 123. |  Kowa Company, Ltd. Nagoya, Japan | | Commercial | VIEW |
| 124. |  | | Commercial | VIEW |
| 125. |  Kusum Healthcare Pvt Ltd New Delhi, India | | - | VIEW |
| 126. |  | | Commercial | VIEW |
| 127. |  LEO Pharma Ballerup, Copenhagen, Denmark | | Phase 2, Phase 3, and Commercial | VIEW |
| 128. |  Laboratoires Servier Orléans, France | | Preclinical through Commercial | VIEW |
| 129. |  Laboratoires Théa Clermont-Ferrand, France | | Phase 1|Phase 2|Phase 3|Commercial | VIEW |
| 130. |  Laboratoires Théa Clermont-Ferrand, France | | Phase 1|Phase 2|Phase 3|Commercial | VIEW |
| 131. |  Laboratoires Théa Clermont-Ferrand, France | | Commercial | VIEW |
| 132. |  Laboratorios Senosiain Mexico City, Mexico | | Commercial | VIEW |
| 133. |  Libbs Farmacêutica São Paulo, Brazil | | Commercial | VIEW |
| 134. |  Lifespan (now Brown University Health) Providence, USA | | Commercial | VIEW |
| 135. |  Lupin Limited Mumbai, India | | Multiple - Commercial to Phase 3 | VIEW |
| 136. |  Luye Pharma Group Hong Kong, China | | Commercial | VIEW |
| 137. |  MSD Rahway, New Jersey, USA | | Commercial | VIEW |
| 138. |  MSN Laboratories Hyderabad, India | | Commercial | VIEW |
| 139. |  Macleods Pharmaceuticals Limited Mumbai, India | | Commercial | VIEW |
| 140. |  Mankind Pharma Limited New Delhi, India | | Commercial & Clinical | VIEW |
| 141. |  Marjan Farma São Paulo, Brazil | | Commercial | VIEW |
| 142. |  McKesson Corporation Irving, Texas, USA | | Commercial | VIEW |
| 143. |  Medac Pharm / medac GmbH Wedel, Germany (near Hamburg) | | Commercial|Phase 2|Preclinical | VIEW |
| 144. |  Mega Lifesciences Bangkok, Thailand | | Commercial | VIEW |
| 145. |  Meiji Seika Pharma Tokyo, Japan | | Phase 3 | VIEW |
| 146. |  Menarini Asia-Pacific Singapore, Singapore | | Commercial | VIEW |
| 147. |  Merck & Co., Inc. Rahway, New Jersey, United States | | Phase 1-Phase 3 and Commercial | VIEW |
| 148. |  Merck KGaA Darmstadt, Germany | | Phase 3 | VIEW |
| 149. |  Merck KGaA, Darmstadt, Germany Darmstadt, Germany | | Commercial | VIEW |
| 150. |  Merck KGaA, Darmstadt, Germany Darmstadt, Germany | | Commercial | VIEW |
| 151. |  Mezzan Holding Company Kuwait City, Kuwait | | Commercial | VIEW |
| 152. |  Nagase & Co., Ltd. Tokyo, Japan | | Commercial | VIEW |
| 153. |  Neutec Pharmaceutical Istanbul, Turkey | | Commercial | VIEW |
| 154. |  Normon Tres Cantos, Madrid, Spain | | Commercial | VIEW |
| 155. |  Novartis Basel, Switzerland | | Phase 2, Phase 3, Commercial | VIEW |
| 156. |  Novo Nordisk Bagsværd, Denmark | | Commercial | VIEW |
| 157. |  Novo Nordisk Bagsværd, Denmark | | Phase 1|Phase 2|Phase 3|Commercial | VIEW |
| 158. |  ONO PHARMA UK LTD London, United Kingdom | | Phase 1 through Commercial | VIEW |
| 159. |  ONO Pharmaceutical Osaka, Japan (Chuo-ku) | | Phase 1-Phase 3 | VIEW |
| 160. |  Opella Neuilly-sur-Seine, France | | Commercial | VIEW |
| 161. |  Oracle Corporation Austin, Texas, USA | | Commercial | VIEW |
| 162. |  | | Commercial | VIEW |
| 163. |  Orion Corporation Espoo, Finland | | Commercial | VIEW |
| 164. |  Otsuka Pharmaceutical Chiyoda, Tokyo, Japan | | Phase 1 through Commercial | VIEW |
| 165. |  Otsuka Pharmaceutical Chiyoda, Tokyo, Japan | | Phase 1 through Commercial | VIEW |
| 166. |  Otsuka Pharmaceutical Co., Ltd. Tokyo, Japan | | Commercial | VIEW |
| 167. |  Otsuka Pharmaceutical India Private Limited Ahmedabad, India | | Commercial | VIEW |
| 168. |  | | Commercial | VIEW |
| 169. |  PPG Industries Pittsburgh, USA | | Commercial | VIEW |
| 170. |  PT Meprofarm Bandung, Indonesia | | Commercial | VIEW |
| 171. |  Par Health St. Louis, Missouri, United States | | Commercial (focus on generic development and manufacturing) | VIEW |
| 172. |  Pfizer New York, United States | | Phase 1-3 and pending approval | VIEW |
| 173. |  Pharmascience Inc. Montreal, Canada | | Commercial | VIEW |
| 174. |  Philip Morris International Stamford, Connecticut, USA | | Commercial | VIEW |
| 175. |  Pierre Fabre Group Castres, France | | Preclinical|Phase 1|Phase 2|Phase 3|Commercial | VIEW |
| 176. |  Purdue Pharma L.P. Stamford, Connecticut, United States | | Phase 1-Preclinical | VIEW |
| 177. |  Qilu Pharmaceutical 8888 Lvyou Road, High-tech Zone, Jinan, China | | Discovery through Commercial | VIEW |
| 178. |  Radiant Pharmaceuticals Limited Dhaka, Bangladesh | | Commercial | VIEW |
| 179. |  Reckitt Slough, United Kingdom | | Commercial | VIEW |
| 180. |  Recordati S.p.A. Milan, Italy | | Commercial | VIEW |
| 181. |  Renata PLC Dhaka, Bangladesh | | Commercial | VIEW |
| 182. |  | | Discovery|Preclinical|Phase 1|Phase 2|Phase 3|Commercial | VIEW |
| 183. |  | | Commercial | VIEW |
| 184. |  Roche Holding AG (via businesspartner.roche.com portal) Basel, Switzerland | | Phase 1 through Commercial | VIEW |
| 185. |  STADA Arzneimittel AG Bad Vilbel, Germany | | Commercial | VIEW |
| 186. |  STADA Arzneimittel AG Bad Vilbel, Germany | | Commercial | VIEW |
| 187. |  | | Commercial | VIEW |
| 188. |  Sandoz Group AG Basel, Switzerland | | Commercial | VIEW |
| 189. |  | | Preclinical through Phase 3 | VIEW |
| 190. |  Schneider Electric SE Rueil-Malmaison, France | | - | VIEW |
| 191. |  Scientific Centre of Drug and Medical Technology Expertise (SCDMTE) Yerevan, Armenia | | Commercial | VIEW |
| 192. |  Shanghai Pharmaceuticals Holding Co., Ltd. Shanghai, China | | Phase 3 | VIEW |
| 193. |  Shionogi & Co., Ltd. Osaka, Japan | | Commercial | VIEW |
| 194. |  Shionogi & Co., Ltd. Osaka, Japan | | Phase 1|Phase 2|Phase 3|Commercial | VIEW |
| 195. |  Shionogi B.V. (Shionogi Europe) Amsterdam, Netherlands | | Commercial | VIEW |
| 196. |  Shiseido Group EMEA Paris, France | | - | VIEW |
| 197. |  Siemens AG Munich, Germany | | - | VIEW |
| 198. |  Sino Biopharmaceutical Limited Hong Kong (Corporate) / Beijing (Operations), China | | Commercial | VIEW |
| 199. |  | | Commercial | VIEW |
| 200. |  Sopan Pharmaceuticals Limited Lalitpur, Nepal | | Commercial | VIEW |
| 201. |  Sopharma AD Sofia, Bulgaria | | Commercial | VIEW |
| 202. |  | | Commercial | VIEW |
| 203. |  Square Pharmaceuticals PLC Dhaka, Bangladesh | | Commercial | VIEW |
| 204. |  St. John Fisher University Rochester, New York, USA | | Discovery | VIEW |
| 205. |  Sumitomo Pharma America, Inc. Marlborough, USA | | Commercial | VIEW |
| 206. |  Sun Pharmaceutical Industries Ltd. Mumbai, India | | Commercial | VIEW |
| 207. |  Takeda Pharmaceutical Company Tokyo, Japan | | Phase 3 | VIEW |
| 208. |  Tanabe Pharma Corporation Osaka, Japan | | Commercial | VIEW |
| 209. |  Teva Pharmaceutical Industries Ltd. Tel Aviv, Israel | | Commercial | VIEW |
| 210. |  Teva Pharmaceutical Industries Ltd. Tel Aviv, Israel | | Commercial | VIEW |
| 211. |  Teva Pharmaceutical Industries Ltd. Tel Aviv, Israel | | Commercial | VIEW |
| 212. |  The Adecco Group Zurich, Switzerland | | - | VIEW |
| 213. |  The Coca-Cola Company Atlanta, USA | | N/A | VIEW |
| 214. |  The Procter & Gamble Company Cincinnati, Ohio, USA | | Commercial | VIEW |
| 215. |  Toray Industries, Inc. Nihonbashi Mitsui Tower, 1-1, Nihonbashi-Muromachi 2-chome, Chūō, Tokyo, Japan | | Phase 1 to Phase 2 | VIEW |
| 216. |  Torrent Pharmaceuticals Ahmedabad, India | | Commercial | VIEW |
| 217. |  Troikaa Pharmaceuticals Ahmedabad, Gujarat, India | | Commercial/Phase 4 | VIEW |
| 218. |  UBE Corporation Tokyo, Japan | | Commercial | VIEW |
| 219. |  | | Commercial | VIEW |
| 220. |  | | Commercial | VIEW |
| 221. |  Unilab, Inc. Mandaluyong, Philippines | | Commercial | VIEW |
| 222. |  Viatris Canonsburg, Pennsylvania, United States | | Phase 1 to Commercial | VIEW |
| 223. |  Virbac India Mumbai, India | | Commercial | VIEW |
| 224. |  Warner Chilcott Rockaway, New Jersey, USA (later expanded with Dublin, Ireland operations) | | Marketed/Phase 2-4 | VIEW |
| 225. |  | | Commercial | VIEW |
| 226. |  Wörwag Pharma Böblingen, Germany | | Commercial | VIEW |
| 227. |  Yifan Pharmaceutical Co., Ltd. Hangzhou, China | | Phase 2-3, Commercial | VIEW |
| 228. |  Zoetis Inc. Parsippany, New Jersey, USA | | Commercial | VIEW |
| 229. |  Zuellig Pharma Singapore, Singapore | | Commercial | VIEW |
| 230. |  Zydus Lifesciences Limited Ahmedabad, India | | Phase 1|Phase 2|Phase 3|Commercial | VIEW |
| 231. |  iNova Pharmaceuticals Singapore, Singapore | | Commercial | VIEW |
| 232. |  phactMI Gainesville, Florida, USA | | Commercial | VIEW |
| 233. |  ČSOB Finančná skupina Bratislava, Slovakia | | N/A | VIEW |